$2.78 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 97 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 36.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $155,491,000 | – | 6,462,634 | +100.0% | 5.58% | – |
| Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $150,514,000 | +14.5% | 136,032,000 | +17.2% | 5.41% | +7.2% | |
| MYL | Buy | MYLAN N V | $142,121,000 | +56.7% | 7,464,327 | +133.3% | 5.10% | +46.8% |
| ORTX | Buy | ORCHARD THERAPEUTICS PLCads | $124,841,000 | -13.0% | 8,923,600 | +11.2% | 4.48% | -18.5% |
| Buy | NEVRO CORPnote 1.750% 6/0 | $120,607,000 | +19.5% | 115,776,000 | +15.8% | 4.33% | +11.9% | |
| FIXX | Buy | HOMOLOGY MEDICINES INC | $112,730,000 | -22.2% | 5,760,368 | +10.2% | 4.05% | -27.2% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $89,625,000 | +17.3% | 3,032,987 | +88.5% | 3.22% | +9.9% |
| XENT | Buy | INTERSECT ENT INC | $70,761,000 | +9.7% | 3,109,004 | +55.0% | 2.54% | +2.8% |
| IMMU | Buy | IMMUNOMEDICS INC | $69,147,000 | -5.1% | 4,985,383 | +31.4% | 2.48% | -11.1% |
| XLRN | Buy | ACCELERON PHARMA INC | $53,617,000 | -8.3% | 1,305,174 | +4.0% | 1.93% | -14.1% |
| New | INSULET CORPnote 1.375%11/1 | $52,097,000 | – | 36,650,000 | +100.0% | 1.87% | – | |
| BKD | Buy | BROOKDALE SR LIVING INC | $51,964,000 | +53.0% | 7,207,239 | +39.6% | 1.87% | +43.4% |
| RARX | Buy | RA PHARMACEUTICALS INC | $51,510,000 | +53.1% | 1,713,000 | +14.0% | 1.85% | +43.4% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $51,380,000 | -10.2% | 57,791,000 | 0.0% | 1.85% | -15.8% | ||
| MYOK | MYOKARDIA INC | $49,990,000 | -3.6% | 997,000 | 0.0% | 1.80% | -9.7% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $46,956,000 | +2.1% | 309,025 | -19.9% | 1.69% | -4.4% |
| DPLO | Sell | DIPLOMAT PHARMACY INC | $42,853,000 | +4.6% | 7,036,670 | -0.2% | 1.54% | -2.0% |
| ARGX | Sell | ARGENX SEsponsored adr | $39,784,000 | -19.1% | 281,000 | -28.6% | 1.43% | -24.2% |
| VCEL | Buy | VERICEL CORP | $39,095,000 | +32.2% | 2,069,601 | +22.5% | 1.40% | +23.8% |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $38,356,000 | – | 4,178,219 | +100.0% | 1.38% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $37,084,000 | – | 1,678,022 | +100.0% | 1.33% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $36,907,000 | -9.0% | 391,254 | -22.8% | 1.33% | -14.8% |
| FATE | FATE THERAPEUTICS INC | $34,569,000 | +15.5% | 1,702,897 | 0.0% | 1.24% | +8.3% | |
| ALEC | Sell | ALECTOR INC | $33,192,000 | -9.4% | 1,746,923 | -10.7% | 1.19% | -15.2% |
| SEM | SELECT MED HLDGS CORP | $32,431,000 | +12.6% | 2,043,527 | 0.0% | 1.16% | +5.5% | |
| DEXCOM INCnote 0.750% 5/1 | $31,926,000 | +18.8% | 20,000,000 | 0.0% | 1.15% | +11.4% | ||
| KEMPHARM INCnote 5.500% 2/0 | $31,632,000 | +10.3% | 65,423,000 | 0.0% | 1.14% | +3.3% | ||
| ANAB | Sell | ANAPTYSBIO INC | $30,497,000 | -43.8% | 540,529 | -27.3% | 1.10% | -47.4% |
| EDIT | EDITAS MEDICINE INC | $28,670,000 | +1.2% | 1,158,841 | 0.0% | 1.03% | -5.2% | |
| SIEN | Buy | SIENTRA INC | $28,658,000 | +22.3% | 4,652,306 | +70.4% | 1.03% | +14.6% |
| NTRA | Sell | NATERA INC | $27,658,000 | +1.4% | 1,002,834 | -24.2% | 0.99% | -5.1% |
| New | PTC THERAPEUTICS INCnote 3.000% 8/1 | $27,557,000 | – | 24,877,000 | +100.0% | 0.99% | – | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $27,254,000 | +47.4% | 264,600 | +4.9% | 0.98% | +38.1% |
| XERS | Buy | XERIS PHARMACEUTICALS INC | $27,226,000 | +15.1% | 2,379,901 | +1.1% | 0.98% | +7.8% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $26,971,000 | +45.0% | 1,217,668 | +87.3% | 0.97% | +35.9% |
| EHTH | Sell | EHEALTH INC | $26,768,000 | -2.3% | 310,900 | -29.3% | 0.96% | -8.5% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $26,314,000 | +100.6% | 3,201,222 | +88.2% | 0.94% | +87.9% |
| DFBHU | DFB HEALTHCARE ACQUISTION COunit 01/30/2023 | $25,925,000 | +2.2% | 2,500,000 | 0.0% | 0.93% | -4.3% | |
| EXACT SCIENCES CORPnote 1.000% 1/1 | $25,846,000 | +26.2% | 15,000,000 | 0.0% | 0.93% | +18.2% | ||
| STAA | New | STAAR SURGICAL CO | $25,752,000 | – | 876,512 | +100.0% | 0.92% | – |
| NVRO | Sell | NEVRO CORP | $25,024,000 | -30.9% | 386,000 | -33.4% | 0.90% | -35.3% |
| SILK | New | SILK ROAD MEDICAL INC | $24,183,000 | – | 499,030 | +100.0% | 0.87% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $23,850,000 | -55.2% | 6,292,980 | -3.7% | 0.86% | -58.0% |
| NVTA | Buy | INVITAE CORP | $23,390,000 | +141.7% | 995,312 | +140.9% | 0.84% | +126.4% |
| MOH | Buy | MOLINA HEALTHCARE INC | $21,471,000 | +75.9% | 150,000 | +74.4% | 0.77% | +64.7% |
| PTCT | Buy | PTC THERAPEUTICS INC | $21,195,000 | +137.6% | 471,000 | +98.7% | 0.76% | +122.5% |
| ARVN | ARVINAS INC | $20,258,000 | +49.0% | 921,234 | 0.0% | 0.73% | +39.7% | |
| WRIGHT MED GROUP N Vnote 2.250%11/1 | $20,185,000 | -4.2% | 13,625,000 | 0.0% | 0.72% | -10.3% | ||
| ADUS | ADDUS HOMECARE CORP | $18,956,000 | +17.9% | 252,915 | 0.0% | 0.68% | +10.4% | |
| BOLD | AUDENTES THERAPEUTICS INC | $18,699,000 | -3.0% | 493,901 | 0.0% | 0.67% | -9.1% | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $18,587,000 | -40.3% | 197,000 | -45.9% | 0.67% | -44.0% |
| SWAV | SHOCKWAVE MED INC | $17,820,000 | +70.6% | 312,146 | 0.0% | 0.64% | +59.6% | |
| HUM | New | HUMANA INC | $17,775,000 | – | 67,000 | +100.0% | 0.64% | – |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $17,741,000 | -25.0% | 1,310,259 | 0.0% | 0.64% | -29.8% | |
| AXGN | Sell | AXOGEN INC | $17,648,000 | -52.6% | 891,306 | -49.6% | 0.63% | -55.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $17,461,000 | +13.9% | 669,260 | +69.5% | 0.63% | +6.6% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $17,057,000 | +247.3% | 1,137,142 | +306.1% | 0.61% | +226.1% |
| CNC | Sell | CENTENE CORP DEL | $15,889,000 | -55.1% | 303,000 | -54.6% | 0.57% | -58.0% |
| Buy | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $15,902,000 | +242.2% | 18,000,000 | +260.0% | 0.57% | +220.8% | |
| ANTM | ANTHEM INC | $14,957,000 | -1.7% | 53,000 | 0.0% | 0.54% | -7.9% | |
| MOR | MORPHOSYS AGsponsored ads | $14,484,000 | +6.2% | 600,000 | 0.0% | 0.52% | -0.6% | |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $13,727,000 | +72.1% | 623,933 | +114.4% | 0.49% | +61.1% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $13,702,000 | -2.8% | 607,633 | 0.0% | 0.49% | -9.1% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $13,023,000 | -37.5% | 101,010 | -42.9% | 0.47% | -41.4% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $12,361,000 | – | 235,000 | +100.0% | 0.44% | – |
| ATNX | ATHENEX INC | $12,313,000 | +61.6% | 621,859 | 0.0% | 0.44% | +51.4% | |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $11,750,000 | +1.3% | 1,268,946 | +0.0% | 0.42% | -5.2% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $11,703,000 | – | 287,545 | +100.0% | 0.42% | – |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $11,165,000 | – | 851,005 | +100.0% | 0.40% | – |
| SYBX | SYNLOGIC INC | $10,080,000 | +19.9% | 1,107,643 | 0.0% | 0.36% | +12.4% | |
| TNDM | Buy | TANDEM DIABETES CARE INC | $9,839,000 | +336.5% | 152,500 | +329.6% | 0.35% | +310.5% |
| ARDX | Buy | ARDELYX INC | $9,311,000 | +1.3% | 3,461,298 | +5.4% | 0.33% | -5.4% |
| INSP | Buy | INSPIRE MED SYS INC | $9,165,000 | +16.1% | 151,106 | +8.7% | 0.33% | +8.6% |
| CHWY | New | CHEWY INCcl a | $9,147,000 | – | 261,337 | +100.0% | 0.33% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $8,723,000 | -75.3% | 3,983,025 | -32.4% | 0.31% | -76.9% |
| XFOR | New | X4 PHARMACEUTICALS INC | $8,475,000 | – | 565,000 | +100.0% | 0.30% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $7,867,000 | +100.7% | 2,722,241 | 0.0% | 0.28% | +88.7% | |
| BBIO | New | BRIDGEBIO PHARMA INC | $7,821,000 | – | 290,000 | +100.0% | 0.28% | – |
| SRNE | New | SORRENTO THERAPEUTICS INC | $5,584,000 | – | 2,091,461 | +100.0% | 0.20% | – |
| ALIM | ALIMERA SCIENCES INC | $5,387,000 | -16.0% | 6,052,935 | 0.0% | 0.19% | -21.1% | |
| TELIGENT INC NEWnote 4.750% 5/0 | $5,063,000 | -21.5% | 9,567,000 | 0.0% | 0.18% | -26.3% | ||
| IDYA | New | IDEAYA BIOSCIENCES INC | $4,233,000 | – | 425,000 | +100.0% | 0.15% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $3,795,000 | – | 816,096 | +100.0% | 0.14% | – |
| HARP | HARPOON THERAPEUTICS INC | $3,705,000 | +37.3% | 285,000 | 0.0% | 0.13% | +29.1% | |
| MDCO | New | MEDICINES COput | $3,647,000 | – | 100,000 | +100.0% | 0.13% | – |
| ITMR | ITAMAR MED LTDsponsored ads | $3,455,000 | -5.3% | 314,136 | 0.0% | 0.12% | -11.4% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $3,425,000 | -14.9% | 500,046 | 0.0% | 0.12% | -20.1% | |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $3,381,000 | – | 70,000 | +100.0% | 0.12% | – |
| PFNX | Sell | PFENEX INC | $2,657,000 | -53.2% | 394,255 | -57.1% | 0.10% | -56.4% |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $2,255,000 | -34.3% | 183,600 | -27.5% | 0.08% | -38.6% |
| STIM | NEURONETICS INC | $1,989,000 | -18.0% | 159,000 | 0.0% | 0.07% | -23.7% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $1,751,000 | -46.3% | 415,908 | -12.5% | 0.06% | -49.6% |
| EYEN | EYENOVIA INC | $1,290,000 | -28.2% | 300,000 | 0.0% | 0.05% | -33.3% | |
| KIDS | ORTHOPEDIATRICS CORP | $1,248,000 | -11.8% | 32,000 | 0.0% | 0.04% | -16.7% | |
| MNLO | MENLO THERAPEUTICS INC | $1,189,000 | -23.7% | 198,451 | 0.0% | 0.04% | -28.3% | |
| PRTO | PROTEON THERAPEUTICS INC | $510,000 | -17.2% | 1,224,899 | 0.0% | 0.02% | -25.0% | |
| NEOS | Sell | NEOS THERAPEUTICS INC | $414,000 | -91.2% | 320,993 | -82.2% | 0.02% | -91.7% |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -226,802 | -100.0% | -0.02% | – |
| MLNTQ | Exit | MELINTA THERAPEUTICS INC | $0 | – | -356,952 | -100.0% | -0.05% | – |
| Exit | IGI LABORATORIES INCnote 3.750%12/1 | $0 | – | -1,733,000 | -100.0% | -0.06% | – | |
| SVRA | Exit | SAVARA INC | $0 | – | -250,000 | -100.0% | -0.07% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -846,048 | -100.0% | -0.12% | – |
| AACH | Exit | AAC HLDGS INC | $0 | – | -1,936,027 | -100.0% | -0.14% | – |
| MGTX | Exit | MEIRAGTX HOLDINGS PLC | $0 | – | -234,000 | -100.0% | -0.16% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -3,970,326 | -100.0% | -0.20% | – |
| Exit | NUVASIVE INCnote 2.250% 3/1 | $0 | – | -7,000,000 | -100.0% | -0.30% | – | |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -326,797 | -100.0% | -0.36% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -119,000 | -100.0% | -0.61% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -144,194 | -100.0% | -0.65% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -227,762 | -100.0% | -0.68% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -2,617,543 | -100.0% | -3.48% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -6,462,634 | -100.0% | -6.55% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.